Majority of Landmark Cancer Studies Cannot Be Replicated
April 6th, 2012
Mmm hmm.
Via: Slashdot:
“During a decade as head of global cancer research at Amgen, C. Glenn Begley identified 53 ‘landmark’ publications — papers in top journals, from reputable labs — for his team to reproduce. Begley sought to double-check the findings before trying to build on them for drug development. Result: 47 of the 53 could not be replicated. He described his findings in a commentary piece published on Wednesday in the journal Nature (paywalled) . … But they and others fear the phenomenon is the product of a skewed system of incentives that has academics cutting corners to further their careers.”
Related: American Society for Microbiology: ‘Has Modern Science Become Dysfunctional?’
<!– AD CAN GO HERE
END: AD CAN GO HERE –>
Leave a Reply
You must be logged in to post a comment.